Needs Assessment After Cancer in Patients Treated for Breast Cancer (EACE)

Institut Jean-Godinot

Status: Completed

Conditions: Quality of Life; Breast Neoplasm Female; Fear Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT03902964

2018-A02191-54

Details and patient eligibility

About

observational monocentric study

Full description

observational monocentric study

Primary objective :

Describe post-cancer supportive care needs, assessed by questionnaire in patients treated for breast cancer after completion of treatment and 2 years later.

Secondary objective :

• Correlation between needs after cancer and the fear of recidivism assessed by the scale of the inventory of fear.
• Compare the need for supportive care between the end of treatment and 2 years after.
• Assess needs after cancer according to the stage of the disease
• Evaluate the needs after cancer according to the treatments received: surgery-radiotherapy versus surgery-chemotherapy-radiotherapy.
• Assess needs after cancer according to age and socio-professional category.

Schedule :

The selected patients then received a letter including an information and non-objection note, the post-cancer needs questionnaire, the Fear Inventory severity subscale questionnaire, and the QLQ-C30 questionnaire. A delay of 1 month was chosen to return the questionnaire with a phone call after 15 days for an analysis of responses in February 2019.

Enrollment: 139 patients

Sex: Female

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Women who have been treated for breast cancer and whose treatment ended in 2017 (cohort A) and in 2015 (cohort B), aged between 18 and 80 years, and who declared their non-opposition free and enlightened.

Exclusion criteria

Patients who have been treated for recurrence or 2nd cancer, metastases from the outset, male, refusal to participate.

Trial design

139 participants in 2 patient groups

women treated for breast cancer in 2017 (cohort A)

Description:

all patients who completed breast cancer treatment between January 1 and May 31, 2017. Withdrawal of men, metastatic patients from the outset, patients with a history of breast cancer or any other location, selection of 20 patients with breast cancer in situ at random

women treated for breast cancer in 2015 (cohorte B)

Description:

all patients who completed breast cancer treatment between January 1 and 31 May 2015. Withdrawal of men, metastatic patients from the outset, patients with a history of breast cancer or any other location, selection of 20 patients with breast cancer in situ at random